Anna SE Cuomo

May 16, 2024 | medrxiv.org | Wei Zhou |Anna SE Cuomo |Angli Xue |Masahiro Kanai

B.M.N. is a member of the scientific advisory board at Deep Genomics and Neumora. M.D. is a founder of Maze Therapeutics. W.Z. was supported by the National Human Genome Research Institute of the National Institutes of Health under award number K99/R00HG012222. A.C. was supported by an EMBO Long Term Postdoctoral Fellowship (EMBO ALTF 424-2022). B.M.N. is supported by the Novo Nordisk Foundation (NNF21SA0072102) and R01MH101244. BMN and GC are supported by R37MH107649.